Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant cells while sparing normal tissues.
Fresenius Medical Care names Martin Fischer as CFO
Name: Martin Fischer New title: CFO of Fresenius Medical Care Previous title: Head of finance for Siemens Healthineers Diagnostics Division Fischer will join Fresenius Medical